RhumbLine Advisers’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.45M Buy
61,807
+7,047
+13% +$736K 0.01% 1283
2025
Q1
$6.39M Buy
54,760
+3,515
+7% +$410K 0.01% 1229
2024
Q4
$4.34M Sell
51,245
-148
-0.3% -$12.5K ﹤0.01% 1495
2024
Q3
$4.62M Sell
51,393
-3,538
-6% -$318K ﹤0.01% 1472
2024
Q2
$4.42M Buy
54,931
+2,674
+5% +$215K ﹤0.01% 1463
2024
Q1
$4.17M Buy
52,257
+1,620
+3% +$129K ﹤0.01% 1503
2023
Q4
$4.03M Sell
50,637
-208
-0.4% -$16.6K ﹤0.01% 1550
2023
Q3
$3.55M Buy
50,845
+4,135
+9% +$289K ﹤0.01% 1536
2023
Q2
$3.36M Buy
46,710
+2,633
+6% +$189K ﹤0.01% 1619
2023
Q1
$2.72M Buy
44,077
+1,138
+3% +$70.2K ﹤0.01% 1647
2022
Q4
$3.31M Buy
42,939
+4,083
+11% +$315K ﹤0.01% 1530
2022
Q3
$1.73M Buy
38,856
+4,372
+13% +$195K ﹤0.01% 1841
2022
Q2
$1.32M Buy
34,484
+5,063
+17% +$194K ﹤0.01% 1994
2022
Q1
$1.22M Sell
29,421
-165
-0.6% -$6.83K ﹤0.01% 2051
2021
Q4
$1.12M Sell
29,586
-344
-1% -$13K ﹤0.01% 2160
2021
Q3
$986K Buy
29,930
+366
+1% +$12.1K ﹤0.01% 2227
2021
Q2
$1.99M Sell
29,564
-1,168
-4% -$78.8K ﹤0.01% 1949
2021
Q1
$1.74M Sell
30,732
-4,968
-14% -$281K ﹤0.01% 1972
2020
Q4
$2.91M Buy
35,700
+1,041
+3% +$84.8K ﹤0.01% 1656
2020
Q3
$2.47M Sell
34,659
-9,260
-21% -$660K ﹤0.01% 1557
2020
Q2
$3.61M Buy
43,919
+5,888
+15% +$485K 0.01% 1393
2020
Q1
$2.24M Buy
38,031
+3,455
+10% +$203K ﹤0.01% 1488
2019
Q4
$3.57M Buy
34,576
+2,777
+9% +$287K 0.01% 1462
2019
Q3
$644K Buy
31,799
+525
+2% +$10.6K ﹤0.01% 2233
2019
Q2
$805K Buy
+31,274
New +$805K ﹤0.01% 2154
2017
Q2
Sell
-13,688
Closed -$53K 2927
2017
Q1
$53K Buy
+13,688
New +$53K ﹤0.01% 2818